FindTrial
Sign In

External validation of warfarin dosing softwares by Maximum a Posteriori Bayesian Method

External validation of warfarin dosing softwares by Maximum a Posteriori Bayesian Method

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100052481
Enrollment
Unknown
Registered
2021-10-28
Start date
2021-11-01
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

post Heart Valve Prosthesis Surgery

Interventions

Group 1:N/A

Sponsors

Shanghai Chest Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients hospitalized with warfarin from January 2017 to July 2021; 2. The number of in-hospital INR monitoring >==4 times since the use of warfarin; 3. Known patient warfarin-related gene polymorphisms (CYP2C9 and VKORC1) and baseline INR values; 4. Those who have signed the general informed consent.

Exclusion criteria

Exclusion criteria: Patients with missing basic information.

Design outcomes

Primary

MeasureTime frame
International Standard Ratio;—

Countries

China

Contacts

Public ContactWen Haini

Shanghai Chest Hospital

wenhaini99@163.com+86 15601679477

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026